An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain

Inclusion Criteria

• •Subjects who completed the 18-week study period in Study A0081107 conducted for chronic neuropathic pain after spinal cord injury;
• •Subjects who completed assessments of all efficacy endpoints until the end of the treatment phase of the preceding Study A0081107 (V7);
• •Subjects with central neuropathic pain after stroke or multiple sclerosis;
• •At least 6 months have passed after the onset of central neuropathic pain;
• •Pain VAS at least 40mm in Visit 1 and Visit 2;